Skip to main content
Fig. 2 | Molecular Cancer

Fig. 2

From: ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells

Fig. 2

Varied ARHGEF15 expression levels in the pancreatic cancer cell lines. The ARHGEF15 mRNA expression levels were determined in 11 pancreatic cancer cell lines by real-time RT-PCR (n = 3). The relative gene expression levels of ARHGEF15 represented in fold values relative to the minimum expression level in the AsPC-1 cells (a and b). c The protein expression levels of ARHGEF15 in Hs766T, MIAPaCa-2 and AsPC-1 cells were determined by Western blotting (n = 3)

Back to article page

Molecular Cancer

ISSN: 1476-4598